Inhibition of Inflammatory Responses by Leukocyte Ig-Like Receptors

Advances in Immunology

Volumn 91, Issue , 2006, Pages 251-272

  Katz, Howard R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR 1; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR 2; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR 3; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR 4; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR 5; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ALLOIMMUNITY; ANTIINFLAMMATORY ACTIVITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; CYTOTOXICITY; DISEASE SEVERITY; DOWN REGULATION; EXPERIMENTAL MOUSE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOREGULATION; IMMUNOSTIMULATION; INCIDENCE; INFLAMMATION; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROBIAL ACTIVITY; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; REVIEW; STATISTICAL DISTRIBUTION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; HUMANS; INFLAMMATION; LEUKOCYTES; MICE; RECEPTORS, IMMUNOLOGIC;

EID: 33747859680     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2776(06)91007-4     Document Type: Review

References (89)

1. Allan D.S., Colonna M., Lanier L.L., Churakova T.D., Abrams J.S., Ellis S.A., McMichael A.J., and Braud V.M. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J. Exp. Med. 189 (1999) 1149-1156
2. Allen R.L., Bowness P., and McMichael A. The role of HLA-B27 in spondyloarthritis. Immunogenetics 50 (1999) 220-227
3. Allen R.L., Raine T., Haude A., Trowsdale J., and Wilson M.J. Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures. J. Immunol. 167 (2001) 5543-5547
4. Aractingi S., Briand N., Le Danff C., Viguier M., Bachelez H., Michel L., Dubertret L., and Carosella E.D. HLA-G and NK receptor are expressed in psoriatic skin: A possible pathway for regulating infiltrating T cells?. Am. J. Pathol. 159 (2001) 71-77
5. Arm J.P., Gurish M.F., Reynolds D.S., Scott H.C., Gartner C.S., Austen K.F., and Katz H.R. Molecular cloning of gp49, a cell surface antigen that is preferentially expressed by mouse mast cell progenitors and is a new member of the immunoglobulin superfamily. J. Biol. Chem. 266 (1991) 15966-15973
6. Arm J.P., Nwankwo C., and Austen K.F. Molecular identification of a novel family of human immunoglobulin superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor. J. Immunol. 159 (1997) 2342-2349
7. Beavitt S.J., Harder K.W., Kemp J.M., Jones J., Quilici C., Casagranda F., Lam E., Turner D., Brennan S., Sly P.D., Tarlinton D.M., Anderson G.P., et al. Lyn-deficient mice develop severe, persistent asthma: Lyn is a critical negative regulator of Th2 immunity. J. Immunol. 175 (2005) 1867-1875
8. Beinhauer B.G., McBride J.M., Graf P., Pursch E., Bongers M., Rogy M., Korthauer U., De Vries J.E., Aversa G., and Jung T. Interleukin 10 regulates cell surface and soluble LIR-2 (CD85d) expression on dendritic cells resulting in T cell hyporesponsiveness in vitro. Eur. J. Immunol. 34 (2004) 74-80
9. Bellon T., Kitzig F., Sayos J., and Lopez-Botet M. Mutational analysis of immunoreceptor tyrosine-based inhibition motifs of the Ig-like transcript 2 (CD85j) leukocyte receptor. J. Immunol. 168 (2002) 3351-3359
10. Berg K.L., Carlberg K., Rohrschneider L.R., Siminovitch K.A., and Stanley E.R. The major SHP-1-binding, tyrosine-phosphorylated protein in macrophages is a member of the KIR/LIR family and an SHP-1 substrate. Oncogene 17 (1998) 2535-2541
11. Berg L., Riise G.C., Cosman D., Bergstrom T., Olofsson S., Karre K., and Carbone E. LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients. Lancet 361 (2003) 1099-1101
12. Blery M., Kubagawa H., Chen C.-C., Vely F., Cooper M.D., and Vivier E. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1. Proc. Natl. Acad. Sci. USA 95 (1998) 2446-2451
13. Borges L., Hsu M.-L., Fanger N., Kubin M., and Cosman D. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J. Immunol. 159 (1997) 5192-5196
14. Castells M.C., Wu X., Arm J.P., Austen K.F., and Katz H.R. Cloning of the gp49B gene of the immunoglobulin superfamily and demonstration that one of its two products is an early-expressed mast cell surface protein originally described as gp49. J. Biol. Chem. 269 (1994) 8393-8401
15. 3 interaction inhibits antigen-induced mast cell activation. Nat. Immunol. 2 (2001) 436-442
16. Cella M., Dohring C., Samaridis J., Dessing M., Brockhaus M., Lanzavecchia A., and Colonna M. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J. Exp. Med. 185 (1997) 1743-1751
17. Cella M., Jarrossay D., Facchetti F., Alebardi O., Nakajima H., Lanzavecchia A., and Colonna M. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5 (1999) 919-923
18. Chang C.C., Ciubotariu R., Manavalan J.S., Yuan J., Colovai A.I., Piazza F., Lederman S., Colonna M., Cortesini R., Dalla-Favera R., and Suciu-Foca N. Tolerization of dendritic cells by T(S) cells: The crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3 (2002) 237-243
19. Chapman T.L., Heikeman A.P., and Bjorkman P.J. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 11 (1999) 603-613
20. Chapman T.L., Heikema A.P., West A.P.J., and Bjorkman P.J. Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2). Immunity 13 (2000) 727-736
21. Colonna M., Navarro F., Bellon T., Llano M., Garcia P., Samaridis J., Angman L., Cella M., and Lopez-Botet M. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186 (1997) 1809-1818
22. Colonna M., Samaridis J., Cella M., Angman L., Allen R.L., O'Callaghan C.A., Dunbar R., Ogg G.S., Cerundolo V., and Rolink A. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J. Immunol. 160 (1998) 3096-3100
23. Cosman D., Fanger N., Borges L., Kubin M., Chin W., Peterson L., and Hsu M.L. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7 (1997) 273-282
24. Daheshia M., Friend D.S., Grusby M.J., Austen K.F., and Katz H.R. Increased severity of local and systemic anaphylactic reactions in gp49B1-deficient mice. J. Exp. Med. 194 (2001) 227-233
25. Dietrich J., Cella M., and Colonna M. Ig-like transcript 2 (ILT2)/leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization. J. Immunol. 166 (2001) 2514-2521
26. Eliceiri B.P., and Cheresh D.A. The role of alphav integrins during angiogenesis: Insights into potential mechanisms of action and clinical development. J. Clin. Invest. 103 (1999) 1227-1230
27. Ellis S.A., Palmer M.S., and McMichael A.J. Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule. J. Immunol. 144 (1990) 731-735
28. Fanger N.A., Cosman D., Peterson L., Braddy S.C., Maliszewski C.R., and Borges L. The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes. Eur. J. Immunol. 28 (1998) 3423-3434
29. Feldweg A.F., Friend D.S., Zhou J.S., Kanaoka Y., Daheshia M., Li L., Austen K.F., and Katz H.R. gp49B1 suppresses stem cell factor-induced mast cell activation-secretion and attendant inflammation in vivo. Eur. J. Immunol. 33 (2003) 2262-2268
30. Forte P., Pazmany L., Matter-Reissmann U.B., Stussi G., Schneider M.K., and Seebach J.D. HLA-G inhibits rolling adhesion of activated human NK cells on porcine endothelial cells. J. Immunol. 167 (2001) 6002-6008
31. Gonen-Gross T., Achdout H., Gazit R., Hanna J., Mizrahi S., Markel G., Goldman-Wohl D., Yagel S., Horejsi V., Levy O., Baniyash M., and Mandelboim O. Complexes of HLA-G protein on the cell surface are important for Leukocyte Ig-like Receptor-1 function. J. Immunol. 171 (2003) 1343-1351
32. Gu X., Laouar A., Wan J., Daheshia M., Lieberman J., Yokoyama W.M., Katz H.R., and Manjunath N. The gp49B1 inhibitory receptor regulates IFN-γ responses of T cells and NK cells. J. Immunol. 170 (2003) 4095-4101
33. Harder K.W., Parsons L.M., Armes J., Evans N., Kountouri N., Clark R., Quilici C., Grail D., Hodgson G.S., Dunn A.R., and Hibbs M.L. Gain- and loss-of-function Lyn mutant mice define a critical inhibitory role for Lyn in the myeloid lineage. Immunity 15 (2001) 603-615
34. Hayami K., Fukuta D., Nishikawa Y., Yamashita Y., Inui M., Ohyama Y., Hikida M., Ohmori H., and Takai T. Molecular cloning of novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors. J. Biol. Chem. 272 (1997) 7320-7337
35. Ho L.H., Uehara T., Chen C.C., Kubagawa H., and Cooper M.D. Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B. Proc. Natl. Acad. Sci. USA 96 (1999) 15086-15090
36. Ince M.N., Harnisch B., Xu Z., Lee S.K., Lange C., Moretta L., Lederman M., and Lieberman J. Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function. Immunology 112 (2004) 531-542
37. Ju X.S., Hacker C., Scherer B., Redecke V., Berger T., Schuler G., Wagner H., Lipford G.B., and Zenke M. Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activation. Gene 331 (2004) 159-164
38. Katz H.R., LeBlanc P.A., and Russell S.W. Two classes of mouse mast cells delineated by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 80 (1983) 5916-5918
39. Katz H.R., Benson A.C., and Austen K.F. Activation- and phorbol ester-stimulated phosphorylation of a plasma membrane glycoprotein antigen expressed on mouse IL-3-dependent mast cells and serosal mast cells. J. Immunol. 142 (1989) 919-926
40. Katz H.R., Vivier E., Castells M.C., McCormick M.J., Chambers J.M., and Austen K.F. Mouse mast cell gp49B1 contains two immunoreceptor tyrosine-based inhibition motifs and suppresses mast cell activation when coligated with the high-affinity Fc receptor for IgE. Proc. Natl. Acad. Sci. USA 93 (1996) 10809-10814
41. Khosrotehrani K., Le Danff C., Reynaud-Mendel B., Dubertret L., Carosella E.D., and Aractingi S. HLA-G expression in atopic dermatitis. J. Invest. Dermatol. 117 (2001) 750-752
42. Kollnberger S., Bird L.A., Roddis M., Hacquard-Bouder C., Kubagawa H., Bodmer H.C., Breban M., McMichael A.J., and Bowness P. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors. J. Immunol. 173 (2004) 1677-1710
43. Kubagawa H., Burrows P.D., and Cooper M.D. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc. Natl. Acad. Sci. USA 94 (1997) 5261-5266
44. Kubagawa H., Chen C.C., Ho L.H., Shimada T.S., Gartland L., Mashburn C., Uehara T., Ravetch J.V., and Cooper M.D. Biochemical nature and cellular distribution of the paired immunoglobulin-like receptors, PIR-A and PIR-B. J. Exp. Med. 189 (1999) 309-318
45. Kuroiwa A., Yamashita Y., Inui M., Yuasa T., Ono M., Nagabukuro A., Matsuda Y., and Takai T. Association of tyrosine phosphatases SHP-1 and SHP-2, inositol 5-phosphatase SHIP with gp49B1, and chromosomal assignment of the gene. J. Biol. Chem. 273 (1998) 1070-1074
46. LeBlanc P.A., and Biron C.A. Mononuclear phagocyte maturation: A cytotoxic monoclonal antibody reactive with postmonoblast stages. Cell. Immunol. 83 (1984) 242-254
47. LeMaoult J., Zafaranloo K., Le Danff C., and Carosella E.D. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J. 19 (2005) 662-664
48. Lepin E.J., Bastin J.M., Allan D.S., Roncador G., Braud V.M., Mason D.Y., Van der Merwe P.A., McMichael A.J., Bell J.I., Powis S.H., and O'Callaghan C.A. Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors. Eur. J. Immunol. 30 (2000) 3552-3561
49. Lesourne R., Bruhns P., Fridman W.H., and Daëron M. Insufficient phosphorylation prevents FcγRIIB from recruiting the SH2 domain-containing protein-tyrosine phosphatase SHP-1. J. Biol. Chem. 276 (2001) 6327-6336
50. Liang S., Baibakov B., and Horuzsko A. HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. Eur. J. Immunol. 32 (2002) 2418-2426
51. Lila N., Amrein C., Guillemain R., Chevalier P., Latremouille C., Fabiani J.N., Dausset J., Carosella E.D., and Carpentier A. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 105 (2002) 1949-1954
52. Lozano J.M., Gonzalez R., Kindelan J.M., Rouas-Freiss N., Caballos R., Dausset J., Carosella E.D., and Pena J. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 16 (2002) 347-351
53. Lu-Kuo J.M., Joyal D.M., Austen K.F., and Katz H.R. gp49B1 inhibits IgE-initiated mast cell activation through both immunoreceptor tyrosine-based inhibitory motifs, recruitment of the src homology 2 domain-containing phosphatase-1, and suppression of early and late calcium mobilization. J. Biol. Chem. 274 (1999) 5791-5796
54. Maeda A., Kurosaki M., Ono M., Takai T., and Kurosaki T. Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal. J. Exp. Med. 187 (1998) 1355-1360
55. Manavalan J.S., Rossi P.C., Vlad G., Piazza F., Yarilina A., Cortesini R., Mancini D., and Suciu-Foca N. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl. Immunol. 11 (2003) 245-258
56. + tolerogenic endothelial cells, inhibiting alloreactivity. Int. Immunol. 16 (2004) 1055-1068
57. + T-cell clones specific for Mycobacterium tuberculosis. Infect. Immun. 69 (2001) 6022-6029
58. Merlo A., Tenca C., Fais F., Battini L., Ciccone E., Grossi C.E., and Saverino D. Inhibitory receptors CD85j, LAIR-1, and CD152 down-regulate immunoglobulin and cytokine production by human B lymphocytes. Clin. Diagn. Lab. Immunol. 12 (2005) 705-712
59. Moretta A., Bottino C., Vitale M., Pende D., Biassoni R., Mingari M.C., and Moretta L. Receptors for HLA class-I molecules in human natural killer cells. Ann. Rev. Immunol. 14 (1996) 619-648
60. -/- mice. Nat. Immunol. 5 (2004) 623-629
61. Navarro F., Llano M., Bellon T., Colonna M., Geraghty D.E., and Lopez-Botet M. The ILT2 (LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur. J. Immunol. 29 (1999) 277-283
62. Pangault C., Le Friec G., Caulet-Maugendre S., Lena H., Amiot L., Guilloux V., Onno M., and Fauchet R. Lung macrophages and dendritic cells express HLA-G molecules in pulmonary diseases. Hum. Immunol. 63 (2002) 83-90
63. Pereira S., and Lowell C.A. The Lyn tyrosine kinase negatively regulates neutrophil integrin signaling. J. Immunol. 171 (2003) 1319-1327
64. Pereira S., Zhang H., Takai T., and Lowell C.A. The inhibitory receptor PIR-B negatively regulates neutrophil and macrophage integrin signaling. J. Immunol. 173 (2004) 5757-5765
65. Petroff M.G., Sedlmayr P., Azzola D., and Hunt J.S. Decidual macrophages are potentially susceptible to inhibition by class Ia and class Ib HLA molecules. J. Reprod. Immunol. 56 (2002) 3-17
66. Ponte M., Cantoni C., Biassoni R., Tradori-Cappai A., Bentivoglio G., Vitale C., Bertone S., Moretta A., Moretta L., and Mingari M.C. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: Decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc. Natl. Acad. Sci. USA 96 (1999) 5674-5679
67. Samaridis J., and Colonna M. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: Structural evidence for new stimulatory and inhibitory pathways. Eur. J. Immunol. 27 (1997) 660-665
68. Saverino D., Fabbi M., Ghiotto F., Merlo A., Bruno S., Zarcone D., Tenca C., Tiso M., Santoro G., Anastasi G., Cosman D., Grossi C.E., et al. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions. J. Immunol. 165 (2000) 3742-3755
69. Saverino D., Merlo A., Bruno S., Pistoia V., Grossi C.E., and Ciccone E. Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen-stimulated human T cells. J. Immunol. 168 (2002) 207-215
70. Seldin D.C., Adelman S., Austen K.F., Stevens R.L., Hein A., Caulfield J.P., and Woodbury R.G. Homology of the rat basophilic leukemia cell and the rat mucosal mast cell. Proc. Natl. Acad. Sci. USA 82 (1985) 3871-3875
71. Shiroishi M., Tsumoto K., Amano K., Shirakihara Y., Colonna M., Braud V.M., Allan D.S., Makadzange A., Rowland-Jones S., Willcox B., Jones E.Y., Van der Merwe P.A., et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc. Natl. Acad. Sci. USA 100 (2003) 8856-8861
72. Sloane D.E., Tedla N., Awoniyi M., MacGlashan Jr. D.W., Borges L., Austen K.F., and Arm J.P. Leukocyte immunoglobulin-like receptors: Novel innate receptors for human basophil activation and inhibition. Blood 104 (2004) 2832-2839
73. Stetson C.A., and Good R.A. Shwartzman phenomenon-participation of polymorphonuclear leukocytes. J. Exp. Med. 93 (1951) 49-53
74. Tedla N., Gibson K., McNeil H.P., Cosman D., Borges L., and Arm J.P. The co-expression of activating and inhibitory leukocyte immunoglobulin-like receptors in rheumatoid synovium. Am. J. Pathol. 160 (2002) 425-431
75. Tedla N., Bandeira-Melo C., Tassinari P., Sloane D.E., Samplaski M., Cosman D., Borges L., Weller P.F., and Arm J.P. Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7. Proc. Natl. Acad. Sci. USA 100 (2003) 1174-1179
76. Tenca C., Merlo A., Merck E., Bates E.E., Saverino D., Simone R., Zarcone D., Trinchieri G., Grossi C.E., and Ciccone E. CD85j (leukocyte Ig-like receptor-1/Ig-like transcript 2) inhibits human osteoclast-associated receptor-mediated activation of human dendritic cells. J. Immunol. 174 (2005) 6757-6763
77. Timms J.F., Carlberg K., Gu H.H., Chen H.Y., Kamatkar S., Nadler M.J.S., Rohrschneider L.R., and Neel B.G. Identification of major binding proteins and substrates for the SH2-containing protein tyrosine phosphatase SHP-1 in macrophages. Mol. Cell. Biol. 18 (1998) 3838-3850
78. Uehara T., Blery M., Kang D.W., Chen C.C., Ho L.H., Gartland G.L., Liu F.T., Vivier E., Cooper M.D., and Kubagawa H. Inhibition of IgE-mediated mast cell activation by the paired Ig-like receptor PIR-B. J. Clin. Invest. 108 (2001) 1041-1050
79. -/- mice. Nat. Immunol. 3 (2002) 542-548
80. Velten F.W., Duperrier K., Bohlender J., Metharom P., and Goerdt S. A gene signature of inhibitory MHC receptors identifies a BDCA3(+) subset of IL-10-induced dendritic cells with reduced allostimulatory capacity in vitro. Eur. J. Immunol. 34 (2004) 2800-2811
81. Vlad G., Piazza F., Colovai A., Cortesini R., Della P.F., Suciu-Foca N., and Manavalan J.S. Interleukin-10 induces the upregulation of the inhibitory receptor ILT4 in monocytes from HIV positive individuals. Hum. Immunol. 64 (2003) 483-489
82. Wang L.L., Blasioli J., Plas D.R., Thomas M.L., and Yokoyama W.M. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B. J. Immunol. 162 (1999) 1318-1323
83. Wang L.L., Chu D.T., Dokun A.O., and Yokoyama W.M. Inducible expression of the gp49B inhibitory receptor on NK cells. J. Immunol. 164 (2000) 5215-5220
84. Willcox B.E., Thomas L.M., Chapman T.L., Heikema A.P., West Jr. A.P., and Bjorkman P.J. Crystal structure of LIR-2 (ILT4) at 1.8 A: Differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18. BMC Struct. Biol. 2 (2002) 6
85. Willcox B.E., Thomas L.M., and Bjorkman P.J. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat. Immunol. 4 (2003) 913-919
86. Young N.T., Uhrberg M., Phillips J.H., Lanier L.L., and Parham P. Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL. J. Immunol. 166 (2001) 3933-3941
87. Zhang H., Meng F., Chu C.L., Takai T., and Lowell C.A. The Src family kinases Hck and Fgr negatively regulate neutrophil and dendritic cell chemokine signaling via PIR-B. Immunity 22 (2005) 235-246
88. Zhou J.S., Friend D.S., Feldweg A.F., Daheshia M., Li L., Austen K.F., and Katz H.R. Prevention of lipopolysaccharide-induced microangiopathy by gp49B1: Evidence for an important role for gp49B1 expression on neutrophils. J. Exp. Med. 198 (2003) 1243-1251
89. Zhou J.S., Friend D.S., Lee D.M., Li L., Austen K.F., and Katz H.R. gp49B1 deficiency is associated with increases in cytokine and chemokine production and severity of proliferative synovitis induced by anti-type II collagen mAbs. Eur. J. Immunol. 35 (2005) 1530-1538